Nastech Pharmaceutical Company Inc. is a pharmaceutical company developing products based on applying drug delivery technologies, with approximately 195 patents and applications filed. The Company is developing molecular biology-based technologies for delivering both small and large molecule drugs by nasal administration, along with an extended release oral delivery technology. It is also developing a diverse product portfolio across multiple therapeutic areas, including products targeted for the treatment of sexual dysfunction, obesity, pain management, osteoporosis and multiple sclerosis. The Company operates a drug manufacturing facility in New York. It has research laboratories in Hauppauge, New York and in Bothell, Washington. Nastech's core technical competency in molecular-biology based drug delivery involves the research, development and manufacture of nasally administered prescription pharmaceuticals.